UK EXECUTIVE CHANGE SUMMARY: ValiRx Appoints Biotaspheric CEO As Chair Read More
UK EXECUTIVE CHANGE SUMMARY: Connect Picks Ex-Synthomer CFO As Chair Read More
REPEAT: ValiRx Completes GBP1.2 Million Placing For Trial Close-Out Read More
ValiRx Competes GBP1.2 Million Placing To Fund VAL201 Trial Close-Out Read More
UK EXECUTIVE CHANGE SUMMARY: Immedia Picks COO Penney As Interim CEO Read More
ValiRx Signs Drug Transfer Agreement With Japanese Pharma Firm Read More
UK WINNERS & LOSERS SUMMARY: RBS Rises Despite Profit Sinking Read More
ValiRx Confirms JV Talks For Non-Core Intellectual Property Read More
UK EXECUTIVE CHANGE SUMMARY: Harvest Minerals CFO Leaves To Save Cost Read More
UK Shareholder Meetings Calendar - Next 7 Days Read More
ValiRx Raises GBP200,000 To Improve "Extremely Weak" Capital Position Read More
ValiRx "Critically Short" Of Working Capital, In Funding Discussions Read More
ValiRx Still Faces Going Out Of Business; Proposes New Share Plan Read More
ValiRx Investors Seek Removal Of Directors Morris And Vainikka Read More
ValiRx's Future In Doubt As Investors Say No To Capital Reogranisation Read More
ValiRx Joint Venture Partner Enters Agreement For VAL401 Funding Read More
ValiRx Raises GBP200,000 To Progress Product Development Read More
ValiRx Reveals "Clear Impact" Of VAL201 On Prostate Cancer Patients Read More
ValiRx Granted "Key" US Patent Protection For VAL201 Cancer Treatment Read More
